Roche posts IMpower010 results in resected NSCLC; adds polatuzumab real-world studySep 30Weekly roundup, 9 itemsafimkibartatezolizumabUpdated
Inovio's UCa-001 trial completes; results posted for INO-5401 combo in urothelial carcinomaSep 2Trial updateINO-5401INO-9012
Adagene reports mid-2026 results, muzastotug data across CRC and HCC trialsAug 12Clinical readoutAdagene Inc
Roche results post for two terminated Morpheus umbrella trials; new Phase 1/2 studies registeredAug 7Weekly roundup, 6 itemsatezolizumabBioLineRx, Ltd.
Exelixis Q2 2026 results detail zanzalintinib pipeline progress, narrows guidanceAug 5Quarterly updateExelixisMerck & Co., Inc.
Boehringer Ingelheim registers Phase Ib/II trial pairing obrixtamig with Zai Lab's ZL-1310 in SCLCJul 16Trial updateBoehringer IngelheimZai Lab (Shanghai) Co., Ltd.
Sign inSign in